These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7524496)
21. High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. Phan J; Lee K; Cherry S; Tropea JE; Burke TR; Waugh DS Biochemistry; 2003 Nov; 42(45):13113-21. PubMed ID: 14609321 [TBL] [Abstract][Full Text] [Related]
22. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT). Roller PP; Wu L; Zhang ZY; Burke TR Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503 [TBL] [Abstract][Full Text] [Related]
23. N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding. Burke TR; Yao ZJ; Gao Y; Wu JX; Zhu X; Luo JH; Guo R; Yang D Bioorg Med Chem; 2001 Jun; 9(6):1439-45. PubMed ID: 11408162 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of 4-(alpha-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 src-homology 2 (Grb2 SH2) domain-binding peptides. Kang SU; Worthy KM; Bindu LK; Zhang M; Yang D; Fisher RJ; Burke TR J Med Chem; 2005 Aug; 48(16):5369-72. PubMed ID: 16078854 [TBL] [Abstract][Full Text] [Related]
25. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Eck MJ; Shoelson SE; Harrison SC Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435 [TBL] [Abstract][Full Text] [Related]
26. Functional characterization of the low-molecular-mass phosphotyrosine-protein phosphatase of Acinetobacter johnsonii. Grangeasse C; Doublet P; Vincent C; Vaganay E; Riberty M; Duclos B; Cozzone AJ J Mol Biol; 1998 May; 278(2):339-47. PubMed ID: 9571056 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors. Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123 [TBL] [Abstract][Full Text] [Related]
28. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431 [TBL] [Abstract][Full Text] [Related]
29. Concise and enantioselective synthesis of Fmoc-Pmp(But)2-OH and design of potent Pmp-containing Grb2-SH2 domain antagonists. Li P; Zhang M; Peach ML; Liu H; Yang D; Roller PP Org Lett; 2003 Aug; 5(17):3095-8. PubMed ID: 12916990 [TBL] [Abstract][Full Text] [Related]
30. New syntheses of tetrazolylmethylphenylalanine and O-malonyltyrosine as pTyr mimetics for the design of STAT3 dimerization inhibitors. Dourlat J; Valentin B; Liu WQ; Garbay C Bioorg Med Chem Lett; 2007 Jul; 17(14):3943-6. PubMed ID: 17509878 [TBL] [Abstract][Full Text] [Related]
31. A synthetic tris-sulfotyrosyl dodecapeptide analogue of the insulin receptor 1146-kinase domain inhibits tyrosine dephosphorylation of the insulin receptor in situ. Liotta AS; Kole HK; Fales HM; Roth J; Bernier M J Biol Chem; 1994 Sep; 269(37):22996-3001. PubMed ID: 8083198 [TBL] [Abstract][Full Text] [Related]
32. Utilization of a peptide lead for the discovery of a novel PTP1B-binding motif. Gao Y; Voigt J; Zhao H; Pais GC; Zhang X; Wu L; Zhang ZY; Burke TR J Med Chem; 2001 Aug; 44(18):2869-78. PubMed ID: 11520195 [TBL] [Abstract][Full Text] [Related]
33. A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors. Tulsi NS; Downey AM; Cairo CW Bioorg Med Chem; 2010 Dec; 18(24):8679-86. PubMed ID: 21055952 [TBL] [Abstract][Full Text] [Related]
34. Specificity of T-cell protein tyrosine phosphatase toward phosphorylated synthetic peptides. Ruzzene M; Donella-Deana A; Marin O; Perich JW; Ruzza P; Borin G; Calderan A; Pinna LA Eur J Biochem; 1993 Jan; 211(1-2):289-95. PubMed ID: 7678807 [TBL] [Abstract][Full Text] [Related]
35. Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases. Dong J; Jassim BA; Milholland KL; Qu Z; Bai Y; Miao Y; Miao J; Ma Y; Lin J; Hall MC; Zhang ZY J Med Chem; 2024 Jun; 67(11):8817-8835. PubMed ID: 38768084 [TBL] [Abstract][Full Text] [Related]
36. Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase. Lee K; Gao Y; Yao ZJ; Phan J; Wu L; Liang J; Waugh DS; Zhang ZY; Burke TR Bioorg Med Chem Lett; 2003 Aug; 13(15):2577-81. PubMed ID: 12852970 [TBL] [Abstract][Full Text] [Related]
37. A highly efficient route to enantiomerically pure l-N-Bz-Pmp(t-Bu)2-OH and incorporation into a peptide-based protein tyrosine phosphatase inhibitor. Hubbard CE; Barrios AM Bioorg Med Chem Lett; 2008 Jan; 18(2):679-81. PubMed ID: 18240386 [TBL] [Abstract][Full Text] [Related]
38. Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases. King MJ; Sale GJ Biochem J; 1990 Feb; 266(1):251-9. PubMed ID: 1689998 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of the activity of protein tyrosine phosphate 1C by its SH2 domains. Townley R; Shen SH; Banville D; Ramachandran C Biochemistry; 1993 Dec; 32(49):13414-8. PubMed ID: 7504950 [TBL] [Abstract][Full Text] [Related]
40. Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases. Ramachandran C; Aebersold R; Tonks NK; Pot DA Biochemistry; 1992 May; 31(17):4232-8. PubMed ID: 1373652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]